姓名：蘇怡

照片：

職稱：副教授

專業(yè)：流行病與衛(wèi)生統(tǒng)計(jì)學(xué)

聯(lián)系方式：alddle@hunnu.edu.cn

通訊地址：湖南省長(zhǎng)沙市岳麓區(qū)桐梓坡路371號(hào)，bwin必贏至謹(jǐn)樓預(yù)防醫(yī)學(xué)系衛(wèi)生統(tǒng)計(jì)學(xué)教研室，郵編：410013

簡(jiǎn)介：

博士，副教授，碩士研究生導(dǎo)師。本科于2004年至2009年就讀于bwin必贏預(yù)防醫(yī)學(xué)專業(yè)，2009年至2012年于中山大學(xué)公共衛(wèi)生學(xué)院攻讀流行病與衛(wèi)生統(tǒng)計(jì)學(xué)碩士，2015年至2019年于香港中文大學(xué)bwin必贏攻讀內(nèi)科科學(xué)博士和從事博士后研究工作，并于2017年赴美國(guó)加州大學(xué)舊金山分校-加州太平洋醫(yī)學(xué)中心進(jìn)行訪學(xué)。曾于長(zhǎng)沙市天心區(qū)疾病預(yù)防控制中心從事了三年的基層公共衛(wèi)生服務(wù)工作。主要致力于分子流行病學(xué)及老年人疾病健康研究，在乳腺癌分子流行病學(xué)和老年人骨骼健康、骨折風(fēng)險(xiǎn)及相關(guān)疾病的研究方面取得系列研究成果。以第一作者身份在老年醫(yī)學(xué)一區(qū)雜志《J Am Med Dir Assoc》、骨質(zhì)疏松領(lǐng)域權(quán)威雜志《Osteoporos Int》和《Bone》、以及《Nutrition, metabolism and cardiovascular disease》和《Clin Chim Acta》等國(guó)際期刊發(fā)表SCI論文13篇，會(huì)議摘要及報(bào)告3篇，及以共同作者身份發(fā)表SCI論文10篇，相關(guān)研究結(jié)果獲得國(guó)內(nèi)外同行認(rèn)可，總引用次數(shù)170余次；曾參編人民衛(wèi)生出版社論著《腫瘤分子流行病學(xué)》；并于2016年，在新加坡獲國(guó)際骨質(zhì)疏松基金會(huì)授予的“杰出青年研究者”稱號(hào)。

主持科研項(xiàng)目（課題）：

1.國(guó)家自然科學(xué)基金委員會(huì),青年項(xiàng)目, 82003541,膳食炎性程度和色氨酸及其交互效應(yīng)與老年糖尿病人骨質(zhì)健康相關(guān)性的研究, 2021-01至2023-12，24萬(wàn)元。

2.湖南省教育廳，優(yōu)秀青年項(xiàng)目，20B367，色氨酸與老年糖尿病人骨微結(jié)構(gòu)健康的相關(guān)性及膳食影響因素研究，2021-01至2023-12，5萬(wàn)元。

3.湖南師范大學(xué)“海外優(yōu)秀博士”人才引進(jìn)項(xiàng)目啟動(dòng)經(jīng)費(fèi)，10萬(wàn)元。

代表性學(xué)術(shù)論文（*為共同第一作者)：

1.Yi Su, Freddy M H Lam, Jason Leung, Wing-Hoi Cheung, Suzanne C Ho, Timothy Kwok (2020) The Predictive Value of Sarcopenia and Falls for 2-Year Major Osteoporotic Fractures in Community-Dwelling Older Adults.Calcif Tissue Int107(2):151-159.

2.Su Y,Leung JCS, Lee Jenny, Ho Kin-fai, Kwok T (2020) The effect of physical activity on dose-relationship between serum 25-hydroxyvitamin D and cardiovascular health events in older adults.Nutrition, metabolism and cardiovascular disease12;30(4):656-665.

3.Su Y, Elshorbagy A, Turner C, Refsum H, Chan R, Kwok T (2019) Circulating Amino Acids Are Associated with Bone Mineral Density Decline and Ten-year Major Osteoporotic Fracture Risk in Older Community-dwelling Adults.Bone129:115082.

4.Su Y, Kwok TCY, Cummings SR, Yip BHK, Cawthon PM (2019) Can classification and regression tree analysis help identify clinically meaningful risk groups for hip fracture prediction in older US men (the MrOS cohort study)?JBMR plus3(10):e10207.

5.Su Y, Woo JW, Kwok TCY (2019) The Added Value of SARC-F to Prescreening Using FRAX for Hip Fracture Prevention in Older Community Adults.J Am Med Dir Assoc20:83-89.

6.Su Y^*, Lai FTT^*, Yip BHK, Leung JCS, Kwok TCY (2018) Cost-effectiveness of osteoporosis screening strategies for hip fracture prevention in older Chinese people: a decision tree modeling study in the Mr. OS and Ms. OS cohort in Hong Kong.Osteoporos Int29:1793-1805.

7.Su Y, Leung J, Kwok TCY (2017) The role of previous falls in major osteoporotic fracture prediction in conjunction with FRAX in older Chinese men and women: the Mr. OS and Ms. OS cohort study in Hong Kong.Osteoporos Int29(6):1469.

8.Su Y, Leung J, Hans D, Aubry-Rozier B, Kwok TCY (2017) Added clinical use of trabecular bone score to BMD for major osteoporotic fracture prediction in older Chinese people: the Mr. OS and Ms. OS cohort study in Hong Kong.Osteoporos Int28:151-160.

9.Su Y, Leung J, Hans D, Lamy O, Kwok TCY (2017) The added value of trabecular bone score to FRAX? to predict major osteoporotic fractures for clinical use in Chinese older people: the Mr. OS and Ms. OS cohort study in Hong Kong.Osteoporos Int28:111-117.

10. Kwok TCY,Su Y, Khoo CC, Leung J, Kwok A, Orwoll E, Woo J, Leung PC (2017) Predictors of non-vertebral fracture in older Chinese males and females: Mr. OS and Ms. OS (Hong Kong).J Bone Miner Metab35:330-337.

11. Xi J^*,Su Y^*, Beeghly Fadiel A, Lin Y, Su FX, Jia WH, Tang LY, Ren ZF (2014) Association of physical activity and polymorphisms in FGFR2 and DNA methylation related genes with breast cancer risk.Cancer Epidemiol38:708-714.

12.Su Y, Tang LY, Chen LJ, He JR, Su FX, Lin Y, Chen WQ, Xie XM, Ren ZF (2012) Joint effects of febrile acute infection and an interferon-gamma polymorphism on breast cancer risk.PLoS One7:e37275.

13.Su Y, Chen LJ, He JR, Yuan XJ, Cen YL, Su FX, Tang LY, Zhang AH, Chen WQ, Lin Y, Wang SM, Ren ZF (2011) Urinary rubidium in breast cancers.Clin Chim Acta412:2305-2309.

14. Tang LY^*,Su Y^*, He JR, Chen WQ, Su FX, Wu BH, Lin Y, Ren ZF (2012) Urinary titanium and vanadium and breast cancer: a case-control study.Nutr Cancer64:368-376